-
E.
Pisick,
S.
Jagadeesh,
R.
Salgia
(2004)
Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
The Scientific World Journal, 4
-
F.
Bladt,
D.
Riethmacher,
S.
Isenmann,
A.
Aguzzi,
C.
Birchmeier
(1995)
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Nature, 376
-
P.
Ma,
R.
Jagadeeswaran,
S.
Jagadeesh,
M.
Tretiakova,
V.
Nallasura,
E.
Fox,
M.
Hansen,
E.
Schaefer,
K.
Naoki,
A.
Lader,
W.
Richards,
D.
Sugarbaker,
A.
Husain,
J.
Christensen,
R.
Salgia
(2005)
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.
Cancer research, 65 4
-
Hatim
Chhatriwala,
N.
Jafri,
R.
Salgia
(2006)
A review of topoisomerase inhibition in lung cancer
Cancer Biology & Therapy, 5
-
B.
Johnson,
T.
Fischer,
B.
Fischer,
D.
Dunlop,
D.
Rischin,
S.
Silberman,
M.
Kowalski,
D.
Sayles,
S.
Dimitrijević,
C.
Fletcher,
J.
Hornick,
R.
Salgia,
T.
Chevalier
(2003)
Phase II study of imatinib in patients with small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 9 16 Pt 1
-
N.
Levin,
P.
Brzoska,
N.
Gupta,
J.
Minna,
J.
Gray,
M.
Christman
(1994)
Identification of frequent novel genetic alterations in small cell lung carcinoma.
Cancer research, 54 19
-
R.
Kanteti,
Soheil
Yala,
M.
Ferguson,
R.
Salgia
(2009)
MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 28 2
-
P.
Ma,
M.
Tretiakova,
V.
Nallasura,
R.
Jagadeeswaran,
A.
Husain,
R.
Salgia
(2007)
Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion
British Journal of Cancer, 97
-
S.
Shimizu,
T.
Mitsudomi
(2002)
[Molecular abnormalities in lung cancer].
Nihon rinsho. Japanese journal of clinical medicine, 60 Suppl 5
-
K.
Noda,
Y.
Nishiwaki,
M.
Kawahara,
S.
Negoro,
T.
Sugiura,
A.
Yokoyama,
M.
Fukuoka,
K.
Mori,
Koshiro
Watanabe,
T.
Tamura,
Seiichiro
Yamamoto,
N.
Saijo
(2002)
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.
The New England journal of medicine, 346 2
-
J.
Chute,
Timothy
Chen,
E.
Feigal,
R.
Simon,
B.
Johnson
(1999)
Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 6
-
P.
Jänne,
B.
Freidlin,
S.
Saxman,
David
Johnson,
R.
Livingston,
F.
Shepherd,
B.
Johnson
(2002)
Twenty‐five years of clinical research for patients with limited‐stage small cell lung carcinoma in North America
Cancer, 95
-
J.
Bigby
(1988)
Harrison's Principles of Internal Medicine
Archives of Dermatology, 124
-
J.
Ben-Ezra,
M.
Kornstein,
M.
Grimes,
Geoffrey
Krystalt
(1994)
Small cell carcinomas of the lung express the Bcl-2 protein.
The American journal of pathology, 145 5
-
B.
Roth,
D.
Johnson,
L.
Einhorn,
L.
Schacter,
N.
Cherng,
H.
Cohen,
J.
Crawford,
J.
Randolph,
J.
Goodlow,
G.
Broun
(1992)
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 10 2
-
S.
Dooley,
I.
Wundrack,
N.
Blin,
C.
Welter
(1995)
Coexpression pattern of c-myc associated genes in a small cell lung cancer cell line with high steady state c-myc transcription.
Biochemical and biophysical research communications, 213 3
-
N.
Ikegaki,
M.
Katsumata,
J.
Minna,
Y.
Tsujimoto
(1994)
Expression of bcl-2 in small cell lung carcinoma cells.
Cancer research, 54 1
-
S.
Naylor,
B.
Johnson,
J.
Minna,
A.
Sakaguchi
(1987)
Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer
Nature, 329
-
N.
Fausto
(1991)
Hepatocyte growth factor receptor and the c-met oncogene Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802?804
Hepatology, 14
-
F.
Cecchi,
D.
Rabe,
D.
Bottaro
(2010)
Targeting the HGF/Met signalling pathway in cancer.
European journal of cancer, 46 7
-
R.
Govindan,
N.
Page,
D.
Morgensztern,
W.
Read,
R.
Tierney,
A.
Vlahiotis,
E.
Spitznagel,
J.
Piccirillo
(2006)
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 28
-
P.
Ma,
T.
Kijima,
G.
Maulik,
E.
Fox,
M.
Sattler,
J.
Griffin,
B.
Johnson,
R.
Salgia
(2003)
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Cancer research, 63 19
-
N.
Dubrawsky
(1989)
Cancer statistics
CA: A Cancer Journal for Clinicians, 39
-
A.
Nusrat,
C.
Parkos,
A.
Bacarra,
P.
Godowski,
C.
Delp-Archer,
E.
Rosen,
J.
Madara
(1994)
Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epi
The Journal of clinical investigation, 93 5
-
Nicholas
Wolff,
Dwight
Randle,
M.
Egorin,
J.
Minna,
R.
Ilaria
(2004)
Imatinib Mesylate Efficiently Achieves Therapeutic Intratumor Concentrations in Vivo but Has Limited Activity in a Xenograft Model of Small Cell Lung Cancer
Clinical Cancer Research, 10
-
D.
Bottaro,
J.
Rubin,
D.
Faletto,
A.
Chan,
T.
Kmiecik,
G.
Woude,
S.
Aaronson
(1991)
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.
Science, 251 4995
-
B.
Peruzzi,
D.
Bottaro
(2006)
Targeting the c-Met Signaling Pathway in Cancer
Clinical Cancer Research, 12
-
M.
Sattler,
Yuri
Pride,
P.
Ma,
Jessica
Gramlich,
Stephanie
Chu,
Laura
Quinnan,
Sheri
Shirazian,
C.
Liang,
K.
Podar,
J.
Christensen,
R.
Salgia
(2003)
A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.
Cancer research, 63 17
-
T.
Harrison
(1955)
Principles of internal medicine
The American Journal of the Medical Sciences, 230
-
Eric
Kim,
R.
Salgia
(2009)
MET pathway as a therapeutic target.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 4 4
-
R.
Siegel,
D.
Naishadham,
A.
Jemal
(2012)
Cancer statistics, 2012
CA: A Cancer Journal for Clinicians, 62
-
A.
Hermes,
B.
Bergman,
R.
Bremnes,
L.
Ek,
S.
Fluge,
C.
Sederholm,
S.
Sundstrøm,
L.
Thaning,
J.
Vilsvik,
U.
Aasebø,
S.
Sörenson
(2008)
Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 26
-
Li
Mao,
J.
Lee,
J.
Kurie,
Youhong
Fan,
S.
Lippman,
J.
Lee,
J.
Ro,
A.
Broxson,
Ren
Yu,
R.
Morice,
B.
Kemp,
F.
Khuri,
Garrett
Walsh,
W.
Hittelman,
W.
Hong
(1997)
Clonal genetic alterations in the lungs of current and former smokers.
Journal of the National Cancer Institute, 89 12
-
I.
Petersen,
H.
Langreck,
G.
Wolf,
A.
Schwendel,
R.
Psille,
P.
Vogt,
M.
Reichel,
T.
Ried,
M.
Dietel
(1997)
Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p.
British Journal of Cancer, 75
-
C.
Birchmeier,
W.
Birchmeier,
E.
Gherardi,
G.
Woude
(2003)
Met, metastasis, motility and more
Nature Reviews Molecular Cell Biology, 4
-
(1991)
Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.
Cancer research, 51 16
-
J.
Whang‐Peng,
P.
Bunn,
C.
Kao-Shan,
Elaine
Lee,
D.
Carney,
A.
Gazdar,
J.
Minna
(1982)
A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC).
Cancer genetics and cytogenetics, 6 2
-
A.
Deffie,
J.
Batra,
Gerald
Goldenberg
(1989)
Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines.
Cancer research, 49 1
-
P.
Comoglio,
S.
Giordano,
L.
Trusolino
(2008)
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Nature Reviews Drug Discovery, 7
-
B.
Peruzzi,
D.
Bottaro
(2008)
Targeting the c-Met signaling pathway in cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 12 12
-
G.
Maulik,
P.
Madhiwala,
S.
Brooks,
P.
Ma,
P.
Ma,
T.
Kijima,
E.
Tibaldi,
E.
Schaefer,
K.
Parmar,
Ravi
Salgia
(2002)
Activated c‐Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer
Journal of Cellular and Molecular Medicine, 6